Male patients with clinical BPH , elevated serum PSA ( > 4ng/ml ) , and significant LUTS ( International Prostate Symptom Score [ IPSS ] 8 ) were randomly assigned to receive doxazosin 4mg daily plus celecoxib 200mg daily ( study group ) or doxazosin 4mg daily alone ( control group ) for 3months .